TRIMTECH Therapeutics

formerly TRIMTECH

First-in-class medicines for cost-effective, disease-modifying neurodegeneration treatment.

Cambridge, United States · Founded 2023 · $45.0M raised

Headquarters
Cambridge
Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$45.0M
Last Round
$14.0M SeedJun 2026
Rounds
2

About

TRIMTECH Therapeutics develops targeted protein degraders called TRIMTACs and TRIMGLUEs designed to selectively eliminate toxic protein aggregates in CNS and inflammatory conditions. The platform is grounded in research into TRIM21, an underutilized ubiquitin ligase, enabling a differentiated approach to treating diseases driven by protein aggregation.

Summary

TRIMTECH Therapeutics is a Biotech company based in Cambridge, United States, founded in 2023. It has raised $45.0M in total across 2 rounds, most recently a $14.0M Seed round in Jun 2026. Investors include Cambridge Innovation Capital, SV Health Investors and Johnson & Johnson Innovation.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

SeedSeed ExtensionJun 2026
$14.0M

Sign up to see all 2 rounds

Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TRIMTECH Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/trimtech-therapeutics"><img src="https://indexed.vc/api/badge/company/trimtech-therapeutics" alt="TRIMTECH Therapeutics on Indexed.vc" width="260" height="76" /></a>